Skip to main content
Signal8

Doshi Dipal

SEC insider (Form 3/4/5 filer). CIK 0001613084. CEO at Entrada Therapeutics, Inc. (TRDA) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in BOSTON, MA.

Companies Doshi Dipal has filed insider reports for

  • Entrada Therapeutics, Inc. (TRDA): Director, Officer, CEO
  • Azenta, Inc. (AZTA): Director
Doshi Dipal profile photo

Doshi Dipal

CIK: 0001613084

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)10 (71.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Entrada Therapeutics, Inc. logo
TRDA

Entrada Therapeutics, Inc.

DirectorOfficer
Azenta, Inc. logo
AZTA

Azenta, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Sep 2, 2026
    Tax Payment
    Direct
    8.7K shares at avg. $7.14$62K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Mar 3, 2026
    Tax Payment
    Direct
    19.2K shares at avg. $11.76$225K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Mar 2, 2026
    Tax Payment
    Direct
    9.9K shares at avg. $11.66$115K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Mar 1, 2026
    Award
    Direct
    139.4K shares-
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Feb 5, 2026
    Award
    Direct
    5.7K shares at avg. $27.85$158K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Sep 2, 2025
    Tax Payment
    Direct
    8.7K shares at avg. $5.43$47K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Mar 3, 2025
    Tax Payment
    Direct
    17.6K shares at avg. $11.68$205K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Mar 1, 2025
    Award
    Direct
    116.2K shares-
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Feb 7, 2025
    Award
    Direct
    4K shares at avg. $52.32$211K
  • Entrada Therapeutics, Inc. logo
    TRDA

    Entrada Therapeutics, Inc.

    Sep 5, 2024
    Tax Payment
    Direct
    826 shares at avg. $15.13$12K

1-10 of 14